Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Ceribelli · SciRah

Researcher profile · Semantic Scholar

M. Ceribelli

Share profile

M. Ceribelli — researcher profile on SciRah

h-index: 33
Works: 117
Citations: 5,507

Most-cited papers

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary Central Nervous System Lymphoma
M. Lionakis, K. Dunleavy, M. Roschewski, B. Widemann +21 more
2017Cancer Cell467 citations Open access
Semantic Scholar
A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma
J. Phelan, Ryan M. Young, D. Webster, S. Roulland +36 more
2018Nature357 citations Open access
Semantic Scholar
Oncogenic mechanisms in Burkitt lymphoma.
R. Schmitz, M. Ceribelli, S. Pittaluga, G. Wright +1 more
2014Cold Spring Harbor Perspectives in Medicine245 citations Open access
Semantic Scholar
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitors
M. Ceribelli, Priscilla N. Kelly, A. Shaffer, G. Wright +15 more
2014Proceedings of the National Academy of Sciences of the United States of America183 citations Open access
Semantic Scholar
Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening
Grant L. Lin, Kelli M. Wilson, M. Ceribelli, Benjamin Z. Stanton +29 more
2019Science Translational Medicine173 citations Open access
Semantic Scholar
Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
Anish Thomas, N. Takahashi, Vinodh N. Rajapakse, Xiaohu Zhang +37 more
2021Cancer Cell159 citations Open access
Semantic Scholar
A Druggable TCF4 and BRD4 dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
M. Ceribelli, Z. Hou, Priscilla N. Kelly, D. Huang +17 more
2016Cancer Cell147 citations Open access
Semantic Scholar
Essential Role of the Linear Ubiquitin Chain Assembly Complex in Lymphoma Revealed by Rare Germline Polymorphisms
Yi-Bin Yang, R. Schmitz, J. Mitala, A. L. Whiting +25 more
2014Cancer Discovery135 citations Open access
Semantic Scholar
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas
Devin Dersh, J. Phelan, Megan E. Gumina, Bo-Ya Wang +15 more
2020Immunity121 citations Open access
Semantic Scholar
Targeting the HTLV-I-Regulated BATF3/IRF4 Transcriptional Network in Adult T Cell Leukemia/Lymphoma
M. Nakagawa, A. Shaffer, M. Ceribelli, Mei-Li Zhang +23 more
2018Cancer Cell113 citations Open access
Semantic Scholar
Isoform-specific expression and feedback regulation of E protein TCF4 control dendritic cell lineage specification
L. Grajkowska, M. Ceribelli, Colleen M. Lau, Margaret E. Warren +7 more
2016Immunity95 citations Open access
Semantic Scholar
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma
Yi-Bin Yang, Priscilla N. Kelly, A. Shaffer, R. Schmitz +21 more
2016Cancer Cell94 citations Open access
Semantic Scholar
Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma
L. Rui, A. Drennan, M. Ceribelli, F. Zhu +12 more
2016Proceedings of the National Academy of Sciences of the United States of America72 citations Open access
Semantic Scholar
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
C. Melani, R. Lakhotia, Stefania Pittaluga, J. Phelan +32 more
2024New England Journal of Medicine66 citations Open access
Semantic Scholar
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
Michael Chiorazzi, L. Rui, Yandan Yang, M. Ceribelli +15 more
2013Proceedings of the National Academy of Sciences of the United States of America66 citations Open access
Semantic Scholar
Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells
A. Bunin, V. Sisirak, H. Ghosh, L. Grajkowska +14 more
2015Immunity61 citations Open access
Semantic Scholar
A landscape of response to drug combinations in non-small cell lung cancer
N. Nair, P. Greninger, Xiaohu Zhang, Adam A. Friedman +26 more
2023Nature Communications60 citations Open access
Semantic Scholar
Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma
C. Heske, Mindy I. Davis, J. Baumgart, Kelli M. Wilson +14 more
2017Clinical Cancer Research57 citations Open access
Semantic Scholar
ETO family protein Mtg16 regulates the balance of dendritic cell subsets by repressing Id2
H. Ghosh, M. Ceribelli, I. Matos, A. Lazarovici +6 more
2014Journal of Experimental Medicine53 citations Open access
Semantic Scholar
Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.
A. Shaffer, J. Phelan, James Q Wang, D. Huang +27 more
2021Blood Cancer Discovery48 citations Open access
Semantic Scholar
IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
Arnold Bolomsky, M. Ceribelli, Sebastian Scheich, Kristina Rinaldi +17 more
2024Cancer Cell34 citations Open access
Semantic Scholar
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.
A. Wilke, C. Doebele, Alena Zindel, K. Lee +41 more
2020Blood33 citations Open access
Semantic Scholar
Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas
Sebastian Scheich, Ji-Ji Chen, Jia-Min Liu, Frank Schnütgen +25 more
2023Cancer Discovery29 citations Open access
Semantic Scholar
Molecular Targets of Glucocorticoids That Elucidate Their Therapeutic Efficacy in Aggressive Lymphomas
Jaewoo Choi, M. Ceribelli, J. Phelan, B. Häupl +20 more
2024Cancer Cell27 citations Open access
Semantic Scholar
Topoisomerase 1 activity during mitotic transcription favors the transition from mitosis to G1.
Anika Wiegard, Vladislav Kuzin, Donald P. Cameron, J. Grosser +12 more
2021Molecules and Cells27 citations Open access
Semantic Scholar
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
Nadia Arang, Simone Lubrano, M. Ceribelli, D. Rigiracciolo +19 more
2023Cell Reports Medicine24 citations Open access
Semantic Scholar
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Yandan Yang, A. Bolomsky, T. Oellerich, Pi-Hsin Chen +22 more
2021bioRxiv21 citations Open access
Semantic Scholar
CellMinerCDB: NCATS is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations
W. Reinhold, Kelli M. Wilson, Fathi Elloumi, K. Bradwell +13 more
2023Cancer Research18 citations Open access
Semantic Scholar
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer
A. Kumari, L. Gesumaria, Yan-Jin Liu, V. Hughitt +11 more
2021bioRxiv17 citations Open access
Semantic Scholar
Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis
C. Melani, R. Lakhotia, S. Pittaluga, M. Miljkovic +14 more
2020Blood17 citations
Semantic Scholar
Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts
Yasuhiro Arakawa, U. Jo, Suresh Kumar, Nai-Yun Sun +19 more
2024Cancer Research Communications15 citations Open access
Semantic Scholar
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
Jerry T. Wu, A. Cheuk, Kristine A Isanogle, C. Robinson +23 more
2023Cancers13 citations Open access
Semantic Scholar
KiRNet: Kinase-centered network propagation of pharmacological screen results
Thomas Bello, M. Chan, Martin G. Golkowski, Andrew G. Xue +5 more
2021Cell Reports Methods13 citations Open access
Semantic Scholar
Targeting NAD+ Metabolism Vulnerability in FH-Deficient Hereditary Leiomyomatosis and Renal Cell Carcinoma with the Novel NAMPT Inhibitor OT-82
Susana S. Najera, C. Ricketts, Laura S. Schmidt, Julia I Medina +26 more
2024Molecular Cancer Therapeutics12 citations
Semantic Scholar
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics
David B. Morse, A. Michalowski, M. Ceribelli, Joachim De Jonghe +13 more
2023Cell Systems12 citations Open access
Semantic Scholar
Schlafen 11 (SLFN11) kills cancer cells undergoing unscheduled re-replication
J. Murai, M. Ceribelli, Hai-Qing Fu, C. Redon +5 more
2023Molecular Cancer Therapeutics12 citations Open access
Semantic Scholar
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
R. Pahwa, J. Dubhashi, A. Singh, Parthav Jailwala +11 more
2022Journal of experimental & clinical cancer research : CR12 citations Open access
Semantic Scholar
An optimal set of inhibitors for Reverse Engineering via Kinase Regularization
S. Rata, Jonathan Scott Gruver, N. Trikoz, A. Lukyanov +6 more
2020bioRxiv12 citations Open access
Semantic Scholar
Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association
A. Wilke, C. Doebele, Alena Zindel, K. Lee +38 more
202310 citations
Semantic Scholar
Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization
Eric J. Vick, Aishlin Hassan, Kwangmin Choi, Joshua Bennett +14 more
2025Leukemia9 citations Open access
Semantic Scholar
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity
M. Ceribelli, F. Tosto, Xiao-Hu Zhang, C. Melani +14 more
2024Proceedings of the National Academy of Sciences of the United States of America9 citations Open access
Semantic Scholar
Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma
Lale Evsen, Patrick J. Morris, C. Thomas, M. Ceribelli
2023Pharmaceuticals9 citations Open access
Semantic Scholar
Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7–Expressing CRPC Models
Benjamin C Brim, A. F. Leon, Erica L Beatson, Jessica D Kindrick +16 more
2025Cancer Research Communications8 citations
Semantic Scholar
High-throughput Approaches to Uncover Synergistic Drug Combinations in Leukemia
Emma J. Chory, Meng Wang, M. Ceribelli, Aleksandra M. Michalowska +14 more
2022bioRxiv8 citations Open access
Semantic Scholar
Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-Cell Lymphoma: Preliminary Analysis of Safety and Efficacy
C. Melani, R. Lakhotia, S. Pittaluga, J. Phelan +12 more
2022Blood6 citations Open access
Semantic Scholar
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML
Christine E. Birdwell, W. Fiskus, Christopher P. Mill, T. Kadia +14 more
2025Leukemia5 citations Open access
Semantic Scholar
Genomic binding of NF-Y in mouse and human cells.
Mirko Ronzio, A. Bernardini, Valentina Taglietti, M. Ceribelli +8 more
2024Genomics5 citations Open access
Semantic Scholar
Phase Ib/II Study of Multi-Targeted Therapy with Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
C. Melani, R. Lakhotia, S. Pittaluga, J. Phelan +32 more
2023Blood5 citations Open access
Semantic Scholar
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors
Ana Corrionero, Xiao-Hu Zhang, Patricia Alfonso, Patrick J. Morris +13 more
2025ACS Pharmacology & Translational Science4 citations Open access
Semantic Scholar
Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed/Refractory and Treatment-Naïve Mantle Cell Lymphoma: Preliminary Analysis of Safety, Efficacy, and Minimal Residual Disease
C. Melani, R. Lakhotia, Stefania Pittaluga, J. Phelan +22 more
2024Blood4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Staudt×21
Invite
L. Staudt — researcher profile on SciRah
C. Thomas×20
Invite
C. Thomas — researcher profile on SciRah
Kelli M. Wilson×16
Invite
Kelli M. Wilson — researcher profile on SciRah
J. Phelan×15
Invite
J. Phelan — researcher profile on SciRah

×14

Invite

Yandan Yang — researcher profile on SciRah

Invite

D. Huang — researcher profile on SciRah

Crystal McKnight×13

Invite

Crystal McKnight — researcher profile on SciRah

Invite

C. Thomas — researcher profile on SciRah

Invite

G. Wright — researcher profile on SciRah

Invite

F. Tosto — researcher profile on SciRah

Invite

Lu Chen — researcher profile on SciRah

S. Pittaluga×9

Invite

S. Pittaluga — researcher profile on SciRah